These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 27637804)
1. Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice. Wu Q; Yang X; Zhang Y; Zhang L; Feng L Exp Neurol; 2016 Nov; 285(Pt A):61-71. PubMed ID: 27637804 [TBL] [Abstract][Full Text] [Related]
2. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]
3. The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease. He Q; Zhang S; Wang J; Ma T; Ma D; Wu L; Zhou M; Zhao L; Chen Y; Liu J; Chen W Mol Neurobiol; 2024 Sep; 61(9):7046-7065. PubMed ID: 38367134 [TBL] [Abstract][Full Text] [Related]
4. Dynamic Changes in Striatal mGluR1 But Not mGluR5 during Pathological Progression of Parkinson's Disease in Human Alpha-Synuclein A53T Transgenic Rats: A Multi-PET Imaging Study. Yamasaki T; Fujinaga M; Kawamura K; Furutsuka K; Nengaki N; Shimoda Y; Shiomi S; Takei M; Hashimoto H; Yui J; Wakizaka H; Hatori A; Xie L; Kumata K; Zhang MR J Neurosci; 2016 Jan; 36(2):375-84. PubMed ID: 26758830 [TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015 [TBL] [Abstract][Full Text] [Related]
6. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model. Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568 [TBL] [Abstract][Full Text] [Related]
7. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression. Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207 [TBL] [Abstract][Full Text] [Related]
8. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice. Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843 [TBL] [Abstract][Full Text] [Related]
10. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression. Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757 [TBL] [Abstract][Full Text] [Related]
11. DNA damage preceding dopamine neuron degeneration in A53T human α-synuclein transgenic mice. Wang D; Yu T; Liu Y; Yan J; Guo Y; Jing Y; Yang X; Song Y; Tian Y Biochem Biophys Res Commun; 2016 Dec; 481(1-2):104-110. PubMed ID: 27818201 [TBL] [Abstract][Full Text] [Related]
12. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model. Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026 [TBL] [Abstract][Full Text] [Related]
13. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. Unger EL; Eve DJ; Perez XA; Reichenbach DK; Xu Y; Lee MK; Andrews AM Neurobiol Dis; 2006 Feb; 21(2):431-43. PubMed ID: 16230020 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian. Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467 [TBL] [Abstract][Full Text] [Related]
15. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease. Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034 [TBL] [Abstract][Full Text] [Related]
16. Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice. Ye M; Chung HS; Lee C; Hyun Song J; Shim I; Kim YS; Bae H Exp Mol Med; 2016 Jul; 48(7):e244. PubMed ID: 27388550 [TBL] [Abstract][Full Text] [Related]
17. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease. Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147 [TBL] [Abstract][Full Text] [Related]
18. D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model. Kim D; Hwang H; Choi S; Kwon SH; Lee S; Park JH; Kim S; Ko HS Acta Neuropathol Commun; 2018 Apr; 6(1):32. PubMed ID: 29703245 [TBL] [Abstract][Full Text] [Related]
19. Tau knockout exacerbates degeneration of parvalbumin-positive neurons in substantia nigra pars reticulata in Parkinson's disease-related α-synuclein A53T mice. Jiao L; Zheng M; Duan J; Wu T; Li Z; Liu L; Xiang X; Tang X; He J; Li X; Zhang G; Ding J; Cai H; Lin X FASEB J; 2020 Sep; 34(9):12239-12254. PubMed ID: 33000527 [TBL] [Abstract][Full Text] [Related]
20. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease. Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]